January 2021 - DTx Pharma

DTx Pharma Promotes Bryan Laffitte, Ph.D. to Chief Scientific Officer

Michael Jaramillo2021-01-28T19:54:36-08:00January 11th, 2021|

SAN DIEGO, January 11, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]

DTx Pharma to Present at the Virtual Biotech Showcase 2021

Michael Jaramillo2021-01-29T08:30:21-08:00January 4th, 2021|

SAN DIEGO, January 4, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]